Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, increases the expression of tumor suppressor Big-H3 via down regulation of its target gene, 05/May/2014, 5.36 am

Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, increases the expression of tumor suppressor TNFAIP8L2 via down regulation of its target gene, 05/May/2014, 5.35 am
May 5, 2014
Fulvestrant, a selective estrogen receptor down-regulator, increases the expression of TNFα via down regulation of its target gene, 5/May/2014, 5,43 am
May 5, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, increases the expression  of tumor suppressor Big-H3  via down regulation of its target gene, 05/May/2014, 5.36 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

 

Comments are closed.